Vacchelli et al. 15 identified a loss-of-function mutation in the allele of the gene coding for formyl peptide receptor 1 (FPR1) that was associated with poor survival in breast and colorectal cancer patients receiving adjuvant chemotherapy. Here, FPR1 is linked to colorectal cancer.